Augment your internal R&D capabilities with the Genialis data analysis platform. With Genialis, your lab will solve high priority NGS informatics challenges to uncover clinically relevant genomic alterations, drug targets, and biomarkers.
Get a 360º view of complex disease-drug relationships— from molecular drivers to druggable targets and indicators of drug response— with a single platform. Genialis supports the analysis of high throughput genomic, transcriptomic, and epigenomic sequencing data to accelerate your drug discovery efforts.
Ensure apples-to-apples interpretation of your NGS data, no matter if it’s public, proprietary, historic, or newly-acquired. With validated informatics pipelines, and built-in normalization and QC/QA workflows, you can confidently, consistently interpret your data.
Genialis enables hassle-free data curation, reducing manual data management from weeks to hours. The platform enforces a standardized nomenclature and annotation taxonomy, so all your data can be analyzed and interpreted in the appropriate context.
Reveal previously unseen patterns across large, heterogeneous datasets to more accurately predict targets and biomarkers. Our team of data scientists will help you define a rigorous data mining program and integrate your data using machine learning or other deep analytical approaches.
“I truly believe we can only accelerate the translation of complex NGS data to the real world once user-friendly software tools are accessible to every researcher, especially for those that lack formal bioinformatics training. This is where Genialis excels.”
Charles Y. Lin, Ph.D., Assistant Professor
Therapeutic Innovation Center at Baylor College of Medicine
Configure your in-house NGS data ecosystem
Democratize access to data-driven insights
Protect your data assets to leverage for IP
Ensure data provenance for IND filing